Tomato-oleoresin supplement prevents doxorubicin-induced cardiac myocyte oxidative DNA damage in rats

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 631, Issue 1, 2007, Pages 26-35

  Ferreira, Ana Lucia Anjos ^a   Salvadori, Daisy Maria Favero ^a   Nascimento, Maria Carolina Munhoz Oliveira ^a   Rocha, Noeme Souza ^a   Correa, Camila R ^a   Pereira, Elenize Jamas ^a   Matsubara, Luiz Shiguero ^a   Matsubara, Beatriz Bojikian ^a   Ladeira, Marcelo Sady Plácido ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cardiotoxicity; DNA damage; Doxorubicin; HPLC; Lycopene; Rat

Indexed keywords

CORN OIL; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; DOXORUBICIN; ENDONUCLEASE; LYC O MATO; LYCOPENE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL LEVEL; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; FEEDING; HEART; HEART MUSCLE CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TOMATO; WISTAR RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CAROTENOIDS; COMET ASSAY; DIETARY SUPPLEMENTS; DNA DAMAGE; DNA GLYCOSYLASES; DOXORUBICIN; ENDODEOXYRIBONUCLEASES; LYCOPERSICON ESCULENTUM; MALE; MYOCYTES, CARDIAC; PLANT EXTRACTS; RATS; RATS, WISTAR;

LYCOPERSICON ESCULENTUM; RATTUS; ZEA MAYS;

EID: 34249681273     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2007.04.003     Document Type: Article

References (59)

1. Deepa P.R., and Varalakshmi P. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 217 (2006) 176-183
2. Li T., Danelisen I., Belló-Klein A., and Singal P.K. Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc. Res. 46 (2000) 523-530
3. Lefrak E.A., Pitha J., Rosenheim S., and Gottieb J.A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32 (1973) 302-314
4. Singal P.K., Iliskovic N., Li T., and Kummar D. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 11 (1997) 931-936
5. Matos H.R., Capelozzi V.L., Gomes O.F., Di Mascio P., and Medeiros M.H.G. Lycopene inhibits DNA damage and liver necrosis in rats treated with ferric nitrilotriacetate. Arch. Biochem. Biophys. 396 (2001) 171-177
6. Skladanowski A., and Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem. Pharmacol. 46 (1993) 375-382
7. Singal P.K., Siveski-Iliskovic N., Hill M., Thomas T.P., and Li T. Combination therapy with probucol prevents adriamycin-induced cardiomyopathy. J. Mol. Cell. Cardiol. 27 (1995) 1055-1063
8. Zhou S., Starkov A., Froberg M.K., Leino R.L., and Wallace K.B. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res. 61 (2001) 771-777
9. Hong Y.M., Kim H.S., and Yoon H.-R. Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of l-carnitine. Pediatr. Res. 51 (2002) 249-255
10. Kitagawa K., Takeda K., Saito K., Okamoto S., Makino K., Maeda H., and Ichihara T. Differences in fatty acid metabolic disorder between ischemic myocardium and doxorubicin-induced myocardial damage: assessment using BMIPP dynamic SPECT with analysis by the Rutland method. J. Nucl. Med. 43 (2002) 1286-1294
11. Li T., Danelisen I., and Singal P.K. Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Mol. Cell. Biochem. 232 (2002) 19-26
12. Lee V., Randhawa A.K., and Singal P.K. Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am. J. Physiol. 261 (1991)
13. Mihm M.J., Yu F., Weinstein D.M., Reiser P.J., and Bauer J.A. Intracelular distribution of peroxinitrite during doxorubicin cardiomyopathy: evidence for selective impaiment of myofibrillar creatine kinase. Br. J. Pharmacol. 135 (2002) 581-588
14. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., and Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197 (1977) 165-167
15. Lebrecht D., Setzer B., Ketelsen U.P., Haberstroh J., and Walker U.A. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 108 (2003) 2423-2429
16. Serrano J., Palmeira C.M., Kuehl D.W., and Wallace K.B. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim. Biophys. Acta 1411 (1999) 201-205
17. Zhou S., Palmeira C.M., and Wallace K.B. Doxorubicin-induced persistent oxidative stress to cardiac myocytes. Toxicol. Lett. 121 (2001) 151-157
18. L'Ecuyer T., Sanjeev S., Thomas R., Novak R., Das L., Campbell W., and Heide R.V. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1273-H1280
19. Wahab M.H.A., Akoul E.E.M.S., and Abdelaziz A.H. Modulatory effects of melatonin and vitamin-E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma bearing mice. Tumori 86 (2000) 157-162
20. Danelisen I., Palace V., Lou H., and Singal P.K. Maintenance of myocardial levels of vitamin A in herat failure due to adriamycin. J. Mol. Cell. Cardiol. 34 (2002) 789-795
21. Yilmaz S., Atessahin A., Sahna E., Karahan I., and Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 218 (2006) 164-171
22. Vile G.F., and Winterbourn C.C. Inhibition of adriamycin-promoted microsomal lipid peroxidation by beta-carotene, alpha-tocopherol and retinol at high and low oxygen partial pressures. FEBS Lett. 238 (1988) 353-356
23. Arab L., and Steck S. Lycopene and cardiovascular disease. Am. J. Clin. Nutr. 71 (2000) 1691S-1695S
24. Stahl W., and Sies H. Physical quenching of singlet oxygen and cis-trans isomerization of carotenoids. Ann. N. Y. Acad. Sci. 691 (1993) 10-19
25. Agarwal S., and Rao V.A. Tomato lycopene and its role in human health and chronic diseases. Can. Med. Assoc. J. 163 (2000) 739-744
26. Stahl W., and Sies H. Antioxidant activity of carotenoids. Mol. Aspects Med. 24 (2003) 345-351
27. Karimi G., Ramezani M., and Abdi A. Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phytother. Res. 19 (2005) 912-914
28. Paiva S.A., Novo R., Matsubara B.B., Matsubara L.S., Azevedo P.S., Minicucci M.F., Campana A.O., and Zornoff L.A. Beta-carotene attenuates the paradoxical effect of tobacco smoke on the mortality of rats after experimental myocardial infarction. J. Nutr. 135 (2005) 2109-2113
29. Yeum K.-J., Lee-Kim Y.C., Yoon S., Lee K.Y., Park I.S., Lee K.S., Kim B.S., Tang G., Russell R.M., and Krinsk N.I. Similar metabolites formed from ß-carotene by either human gastric mucosal homogenates, lipoxygenase or linoleic acid hydroperoxide. Arch. Biochem. Biophys. 321 (1995) 167-174
30. Ferreira A.L.A., Yeum K.-J., Liu C., Smith D., Krinsky N.I., Wang X.-D., and Russell R.M. Tissue distribution of lycopene in ferrets and rats after lycopene supplementation. J. Nutr. 130 (2000) 1256-1260
31. Pool-Zobel B.L., Lotzmann N., Knoll M., Kuchenmeister F., Lambertz R., Leucht U., Scroeder G.U., and Schmezer P. Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples. Environ. Mol. Mutagen. 24 (1994) 23-45
32. Strauss G.H.S. Non-random cell killing in cryopreservation: Implications for the performance of the battery of leukocyte tests (BLT) I. Toxic and imunotoxic effects. Mutat. Res. 252 (1991) 1-15
33. Everett S.M., White K.L., Schorah C.J., Calvert R.J., Skinner C., Miller D., and Axon A.T. In vivo DNA damage in gastric epithelial cells. Mutat. Res. 468 (2000) 73-85
34. Collins A.R., Raslova K., Somorovska M., Petrovska H., Ondrusova A., Vohnout B., Fabry R., and Dusinska M. DNA damage in diabetes: correlation with a clinical marker. Free Radic. Biol. Med. 25 (1998) 373-377
35. Ladeira M.S.P., Rodrigues M.A.M., Freire-Maia D.V., and Salvadori D.M.F. Use of Comet assay to assess DNA damage in patients infected by Helicobacter pylori-Comparisons between visual and image analyses. Mutat. Res. 586 (2005) 76-86
36. Buja L.M., Ferrans V.J., Mayer R.J., Roberts W.C., and Henderson E.S. Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32 (1973) 771-788
37. 111 in monoclonal antimyosin Fab in detecting doxorubicin cardiotoxicity in rats. Morphological and hemodynamic findings. Circulation 86 (1992) 1965-1972
38. Hwang E.S., and Bowen P.E. Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 23 (2005) 97-105
39. Matulka R.A., Hood A.M., and Griffiths J.C. Safety evaluation of a natural tomato oleoresin extract derived from food-processing tomatoes. Regul. Toxicol. Pharmacol. 39 (2004) 390-402
40. Ciaccio M., Valenza M., Tesoriere L., Bongiorno A., Albiero R., and Livrea M.A. Vitamin-A inhibits doxorubicin-induced membrane lipid-peroxidation in rat-tissues in vivo. Arch. Biochem. Biophys. 302 (1993) 103-108
41. Yin X., Wu H., Chen Y., and Kang Y.J. Induction of antioxidants by adriamycin in mouse heart. Biochem. Pharmacol. 56 (1998) 87-93
42. Dziegiel P., Murawska-Cialowicz E., Jethon Z., Januszewska L., Podhorska-Okolow M., Surowiak M., Zawadzki P., Rabczynski J., and Zabel M. Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication. J. Pineal Res. 35 (2003) 183-187
43. Danelisen I., Palace V., Lou H., and Singal P.K. Maintenance of myocardial levels of vitamin A in heart failure due to adriamycin. J. Mol. Cell. Cardiol. 34 (2002) 789-795
44. Erhola M., Kellokumpu-Lehtinen P., Metsa-Ketela T., Alanko K., and Nieminen M.M. Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients. Free Radic. Biol. Med. 21 (1996) 383-390
45. Faure H., Coudray C., Mousseau M., Ducros V., Douki T., Bianchini F., Cadet J., and Favier A. 5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Radic. Biol. Med. 20 (1996) 979-983
46. Sawyer D.B., Fukazawa R., Arstall M.A., and Kelly R.A. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ. Res. 84 (1999) 257-265
47. Pacher P., Liaudet L., Bai P., Virag L., Mabley J.G., Hasko G., and Szabo C. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J. Pharmacol. Exp. Ther. 300 (2002) 862-867
48. Reifen R., Nissenkorn A., Matas Z., and Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J. Gastroenterol. 39 (2004) 514-519
49. Kim C., Kim N., Joo H., Youm J.B., Park W.S., Cuong D.V., Park Y.S., Kim E., Min C.-K., and Han J. Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin. J. Cardiovasc. Pharmacol. 46 (2005) 200-210
50. Antunes L.M., and Takahashi C.S. Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat. Res. 419 (1998) 137-143
51. Porrini M., and Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J. Nutr. 130 (2000) 189-192
52. Pool-Zobel B.L., Bub A., Muller H., Wollowski I., and Rechkemmer G. Consumption of vegetables reduces genetic damage in humans: first results of a human intervention trial with carotenoid-rich foods. Carcinogenesis 18 (1997) 1847-1850
53. Rao A.V., and Agarwal S. Effect of diet and smoking on serum lycopene and lipid peroxidation. Nutr. Res. 18 (1998) 713-721
54. Dušinská M., Vallová B., Ursínyová M., Hladíková V., Smolková B., Wsólová L., Rašlová K., and Collins A.R. DNA damage and antioxidants; fluctuations through the year in a central European population group. Food Chem. Toxicol. 40 (2002) 1119-1123
55. Doroshow J.H. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 43 (1983) 460-472
56. Siveski-Iliskovic N., and Singal P.K. Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am. J. Pathol. 150 (1997) 727-734
57. Abdel-aleem S., el-Merzabani M.M., Sayed-Ahmed M., Taylor D.A., and Lowe J.E. Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. J. Mol. Cell. Cardiol. 29 (1997) 789-797
58. Deepa P.R., and Varalakshmi P. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity. Eur. J. Pharmacol. 478 (2003) 199-205
59. Richelle M., Bortlik K., Liardet S., Hager C., Lambelet P., Baur M., Applegate L.A., and Offord E.A. A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J. Nutr. 132 (2002) 404-408